VERU INC.
Close on Oct 19, 2026
- Market cap
- $53.25M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Dec 16, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2026 Ended Jun 30, 2026 | Aug 10, 2026 | Before market open | – | – | – |
| Q2 FY2026 Ended Mar 31, 2026 | May 13, 2026 | Before market open | – | $-0.12 | – |
| Q1 FY2026 Ended Dec 31, 2025 | Feb 11, 2026 | Before market open | – | $-0.26 | – |
| Q4 FY2025 Ended Sep 30, 2025 | Dec 17, 2025 | Before market open | – | – | – |
| Q3 FY2025 Ended Jun 30, 2025 | Aug 12, 2025 | Before market open | – | $-0.50 | – |
| Q2 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | – | $-0.05 | – |
| Q1 FY2025 Ended Dec 31, 2024 | Feb 13, 2025 | Before market open | – | $-0.06 | – |
| Q3 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | Before market open | $4.00M | $-0.07 | – |
| Q2 FY2024 Ended Mar 31, 2024 | May 8, 2024 | Before market open | $4.10M | $-0.07 | – |
| Q1 FY2024 Ended Dec 31, 2023 | Feb 8, 2024 | Before market open | $2.10M | – | – |
| Q3 FY2023 Ended Jun 30, 2023 | Aug 10, 2023 | Before market open | $3.30M | $0.07 | – |
Press releases
Announcements VERU filed with the SEC
Executive Director, Investor Relations and
Other events · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Material agreement · Other events · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Material agreement · Other events · EX-99.2 to Form 8-K
Executive Director, Investor Relations and Corporate Communications
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and Corporate Communications
Material agreement · Agreement terminated · Acquisition or disposition completed · Other events · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
Material agreement · Agreement terminated · Acquisition or disposition completed · Other events · EX-99.2 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Veru Announces Proposed Public Offering of Common Stock
Material agreement · Other events · EX-99.1 to Form 8-K
Veru Announces Pricing of Public Offering of Common Stock
Material agreement · Other events · EX-99.2 to Form 8-K
Forward looking statements and safe
Material agreement · Other events · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and Corporate Communications
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and Corporate Communications
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and Corporate Communications
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Executive Director, Investor Relations and
Results of operations · EX-99.1 to Form 8-K
Veru Reports Record Fiscal 2021 Full-Year
Results of operations · EX-99.1 to Form 8-K
The Female Health Company Declares Second Quarter Dividend
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares First Quarter Dividend
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares Fourth Quarter Cash
Regulation FD disclosure · EX-99.1 to Form 8-K
William R. Gargiulo, Jr. 231.526.1244
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
FORM 99.1 TO JANUARY 3, 2013 FORM 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Reports Fiscal Year 2011 Results
Results of operations · EX-99.1 to Form 8-K
The Female Health Company Declares
Regulation FD disclosure · EX-99.1 to Form 8-K
The Female Health Company Expects to Report Modest Profit
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K